Breaking News

DSM Acquires Adare Biome for €275 million

DSM is expected to take Adare Biome to a new level and realize the growth potential of postbiotics.

Royal DSM, a global company involved in science-based health, nutrition and bioscience, entered into exclusive negotiations with Adare Pharma Solutions to acquire Adare Biome, a pioneer in the development and manufacturing of postbiotics, for an enterprise value of €275 million. Tom Sellig, CEO of Adare Pharma Solutions, said, “DSM would be the ideal company to take Adare Biome to a new level and realize the growth potential of postbiotics. They have the infrastructure and strong commercializ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters